Optobionics Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

Optobionics General Information

Description

Developer of an artificial retina device created for stimulating and modulating eye sight diseases. The company's device includes microchips that are implanted to neurotrophic rescue effect resulting in a degree of vision recovery that has included visual acuity, contrast and colour perception, and expansion of the visual field, enabling patients to receive treatment of vision loss From retinitis pigmentosa.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 386 Pennsylvania Avenue
  • Suite 3N
  • Glen Ellyn, IL 60137
  • United States
+1 (630)
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • 386 Pennsylvania Avenue
  • Suite 3N
  • Glen Ellyn, IL 60137
  • United States
+1 (630)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Optobionics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Optobionics‘s full profile, request access.

Request a free trial

Optobionics Patents

Optobionics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2009520578-A Charge-integrated artificial retina and method Inactive 20-Dec-2005
WO-2007076347-A1 Charge-integrating retinal prosthesis and method Inactive 20-Dec-2005
WO-2006073995-A2 Activated iridium oxide electrodes and methods for their fabrication Inactive 05-Jan-2005
WO-2006073995-A3 Activated iridium oxide electrodes and methods for their fabrication Inactive 05-Jan-2005
WO-2005110326-A2 Mechanically activated objects for treatment of degenerative retinal disease Inactive 12-Apr-2004 A61N1/36046
To view Optobionics’s complete patent history, request access »

Optobionics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Optobionics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Optobionics‘s full profile, request access.

Request a free trial

Optobionics FAQs

  • When was Optobionics founded?

    Optobionics was founded in 1997.

  • Where is Optobionics headquartered?

    Optobionics is headquartered in Glen Ellyn, IL.

  • What is the size of Optobionics?

    Optobionics has 15 total employees.

  • What industry is Optobionics in?

    Optobionics’s primary industry is Therapeutic Devices.

  • Is Optobionics a private or public company?

    Optobionics is a Private company.

  • What is Optobionics’s current revenue?

    The current revenue for Optobionics is .

  • How much funding has Optobionics raised over time?

    Optobionics has raised $27.1M.

  • Who are Optobionics’s investors?

    ARCH Venture Partners, Advanced Technology Ventures, Alcon, Medtronic, and NASA SBIR/STTR are 5 of 7 investors who have invested in Optobionics.

  • When was Optobionics acquired?

    Optobionics was acquired on 01-Nov-2018.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process